The Annual General Meeting of Shareholders (AGM) took place on Friday 11 May 2012 at DSM’s head office in Heerlen, the Netherlands.
The shareholders or shareholder representatives attending the meeting represented 57.5% of the issued share capital entitled to vote. There is one vote per share and all the resolutions were approved.
The Managing Board elucidated the Annual Report for 2011.
The Financial Statements for 2011 were adopted.
The reserve policy and dividend policy were elucidated.
The dividend per ordinary share to be paid for 2011 being €1.45 was declared. The final dividend (€1.00) to be made available in cash or ordinary shares at the option of the shareholder was adopted.
The members of the Managing Board were released from liability in respect of their managerial activities; the release relates to the data revealed by the annual accounts and/or otherwise communicated to the General Meeting before the annual accounts were approved.
The members of the Supervisory Board were released from liability in respect of their supervisory role; the release relates to the data revealed by the annual accounts and/or otherwise communicated to the General Meeting before the annual accounts were approved.
Mr. Ewald Kist was re-appointed as member of the Supervisory Board.
Mrs Victoria Haynes was appointed as member of the Supervisory Board.
Mrs. Eileen Kennedy was appointed as member of the Supervisory Board.
The proposal to amend the remuneration of the members of the Supervisory Board was approved.
The period during which the Managing Board is authorized to issue ordinary shares was extended.
The period during which the Managing Board is authorized to limit or exclude the preferential right when issuing ordinary shares was extended.
Authorization was granted to the Managing Board to have the company repurchase own shares.
The meeting resolved to reduce the issued capital by cancellation of own shares up to a maximum of the number that is or will be bought by the company (the number of shares to be cancelled shall be determined by the Managing Board and shall be limited to a maximum of 10% of the issued capital as appearing from the Financial Statements for 2011). As a result of the granting of the authorization as requested, the authorization granted last year has been cancelled.
Published 11 May 2012